Copper Cu 64 dotatate is a newly approved Cu labeled somatostatin analog and has several advantages over Ga-labeled somatostatin analogs for positron emission tomography (PET). Copper Cu 64 dotatate has a longer half-life and can be produced once a day as opposed to several times a day, and lower positron energy lending to improved spatial resolution. Furthe...
Copper Cu 64 Dotatate is a radiopharmaceutical used with positron emission tomography(PET) to locate somatostatin receptor-positive neuroendocrine tumors.
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.